Molecular Imaging Techniques to Study the Biodistribution of Orally Administered (99m)Tc-Labelled Naive and Ligand-Tagged Nanoparticles
Areses P, Agüeros MT, Quincoces G, Collantes M, Richter JA, López-Sánchez LM, Sánchez-Martínez M, Irache JM, Peñuelas I.
Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, University Clinic of Navarra, 31008, Pamplona, Spain
Study by molecular imaging the biodistribution of poly(anhydride) nanoparticles after oral administration.
Poly (anhydride) nanoparticles (NP) and cyclodextrin-tagged nanoparticles (CD-NP) were radiolabelled with (99m)Tc. Radiochemical purity was measured with a double-solvent chromatography system and the absence of undesirable components was confirmed by size and polydispersion measurement of the technetium-labelled nanoparticles by photon correlation spectroscopy. Single photon emission computed tomography (SPECT) fused computed tomography (CT) in vivo molecular imaging was used for biodistribution studies in small animals.
SPECT-CT images revealed activity only in the gastrointestinal tract. Thirteen percent of the given dose of CD-NP and 3% of the given dose of conventional NP were found in the stomach at 8 h.
No evidence of translocation or distribution out of gastrointestinal tract was found. CD-NP moved significantly more slowly inside the gut than conventional NP, probably due to their physico-chemical structure that allows stronger interactions with the gut mucosa.
CITATION Mol Imaging Biol. 2010 Dec 16